Maria M. Vaccarezza
Buenos Aires, C, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Corrigendum to "Classic and atypical late infantile neuronal ceroid lipofuscinosis in Latin America: Clinical and genetic aspects, and treatment outcome with cerliponase alfa." [Molecular Genetics and Metabolism ReportsVolume 38 (2024) 101060].
Journal: Molecular genetics and metabolism reports
Published: April 10, 2025
Classic and Atypical Late Infantile Neuronal Ceroid Lipofuscinosis in Latin America: Clinical and Genetic Aspects, and Treatment Outcome with Cerliponase Alfa.
Journal: Molecular genetics and metabolism reports
Published: June 06, 2023
Use of ketogenic dietary therapy for drug-resistant epilepsy in early infancy.
Journal: Epilepsia open
Published: June 01, 2023
Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications.
Journal: Brain : a journal of neurology
Published: March 12, 2021
Clinical and genetic spectrum of SCN2A-associated episodic ataxia.
Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
Published: January 08, 2019
Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group.
Journal: Epilepsia open
Published: April 16, 2018
National consensus on the modified Atkins diet
Journal: Revista de neurologia
Published: April 12, 2016
Dietary therapy is not the best option for refractory nonsurgical epilepsy.
Journal: Epilepsia
Published: June 08, 2015
Recommendations for the clinical management of children with refractory epilepsy receiving the ketogenic diet.
Journal: Archivos argentinos de pediatria
Published: May 15, 2015
Treatment of refractory epilepsy with the modified Atkins diet.
Journal: Archivos argentinos de pediatria
Published: March 27, 2013
Last Updated: 09/26/2026